EMERGENT BIOSOLUTIONS INC. Inventory Write-down
EMERGENT BIOSOLUTIONS INC. (EBS) reported Inventory Write-down of $0 for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2024-11-07
- EMERGENT BIOSOLUTIONS INC. inventory write-down for the quarter ending 2024-09-30 was $0.00.
- EMERGENT BIOSOLUTIONS INC. inventory write-down for the quarter ending 2024-06-30 was $110.20M.
- EMERGENT BIOSOLUTIONS INC. inventory write-down for the quarter ending 2023-09-30 was $0.00.
- EMERGENT BIOSOLUTIONS INC. inventory write-down for the quarter ending 2023-06-30 was $0.00.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month |
|---|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 | $110.20M derived: sum of 2 quarters · filed 2024-11-07 | $110.20M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $110.20M 10-Q · filed 2024-08-07 | $110.20M 10-Q · filed 2024-08-07 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | |
| 2021-09-30 | $41.50M 10-Q · filed 2021-11-05 | ||
| 2021-06-30 | $41.50M 10-Q · filed 2021-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |